Monogram Orthopaedics (MGRM) Stock Price, News & Analysis

Company Overview

Monogram Orthopaedics, traded on Nasdaq under the ticker MGRM, is a commercial-stage medical device company focused on developing and delivering personalized knee replacement solutions. The company’s mission centers on improving patient outcomes in knee arthroplasty by leveraging advanced design and manufacturing methods to tailor implants and instrumentation to each individual’s unique anatomy.

At the core of Monogram’s offering is the Monogram Knee System, which combines proprietary imaging software with additive manufacturing techniques to produce patient-specific implants and surgical instruments. Preoperative MRI or CT scans are used to create a three-dimensional model of the patient’s knee, allowing the system to optimize implant geometry, alignment guides, and cutting blocks. This customized approach aims to enhance implant fit, reduce surgical times, and potentially improve post-operative function and comfort.

Founded in 2018 and headquartered in Menlo Park, California, Monogram Orthopaedics has secured FDA 510(k) clearance for its partial knee replacement system and completed its first commercial cases in leading U.S. orthopedic centers. The company continues to expand its commercial footprint across the United States, with plans to pursue additional regulatory approvals and market entry in select international regions.

Key Stats

• Today's Range: $6.00 to $6.00
• 50-Day Range: $5.71 to $6.22
• 52-Week Range: $2.32 to $6.43
• Volume: N/A
• Average Volume: 253,414 shs
• Market Capitalization: $243.79 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

MGRM Stock Analysis - Frequently Asked Questions

How were Monogram Orthopaedics' earnings last quarter?

Monogram Orthopaedics Inc. (NASDAQ:MGRM) released its quarterly earnings results on Friday, August, 15th. The company reported ($0.16) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by $0.05.

When did Monogram Orthopaedics IPO?

Monogram Orthopaedics (MGRM) raised $17 million in an initial public offering on Thursday, May 18th 2023. The company issued 2,374,641 shares at $7.25 per share.

What other stocks do shareholders of Monogram Orthopaedics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Monogram Orthopaedics investors own include Faraday Future Intelligent Electric (FFIE), Plug Power (PLUG), AMC Entertainment (AMC), CXApp (CXAI), Draganfly (DPRO) and

Company Calendar

• Last Earnings: 8/15/2025
• Today: 5/07/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:MGRM
• CIK: 1769759
• Web: www.monogramorthopedics.com
• Phone: 512-399-2656
• Fax: N/A
• Employees: 28
• Year Founded: 2016

Profitability

• EPS (Trailing Twelve Months): ($0.50)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$16.33 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -126.82%
• Return on Assets: -96.87%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.16
• Quick Ratio: 2.16

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.42 per share
• Price / Book: 14.29

Miscellaneous

• Outstanding Shares: 40,632,000
• Free Float: 29,214,000
• Market Cap: $243.79 million
• Optionable: Not Optionable
• Beta: 0.68